News Wire ~ 3rd Party Press Release
Study: Allergic Reactions Frequent in Children Undergoing Milk OIT
Allergic reactions frequently occur during treatment and a significant proportion can be classified as anaphylactic, according to a new Canadian study.
Aimmune Therapeutics Presents New AR101 Data Including Demonstrated Reduction in Accidental Exposures to Peanut...
AR101-Treated Patients Who Completed PALISADE Had 95% Increased Probability of Tolerating Any Dose of Peanut Protein in Exit Challenge Compared to Placebo.
Boiled Peanut OIT Continues to Show Promise as a Safe and Effective Allergy Treatment
Research from a UK clinical trial finds a new oral immunotherapy option provides sustained unresponsiveness one year after treatment.
Following OIT, Certain Egg Allergy Patients Likely to Consume and Tolerate Egg Five Years...
Subjects achieving sustained unresponsiveness to egg following four years of oral immunotherapy likely to consume and tolerate eggs five years later.
Red Meat Allergy May Develop Due to Tick Saliva, Not Blood Meal Status
Research presented at 2019 AAAAI Annual Meeting finds potential allergen is retained in tick saliva independent of feedings.
Scientists Identify Unique Subtype of Eczema Linked to Food Allergy
Children with both conditions have abnormal skin near eczema lesions, NIH-funded research finds.
FDA Fast Tracks ARS-1 Intranasal Epinephrine Spray
Company provides a novel means of administering emergency epinephrine.
This Immune Cell Function Could Control Deadly Allergic Reactions
Researchers find control point in mast cells that prevents them from being overactivated.
DBV to Resubmit Application to FDA for Viaskin Peanut Approval in Q3 2019
Company allays concerns that BLA would not be resubmitted.
Nima Announces New Tool to Provide Those with Gluten and Peanut Allergies Information on...
Nima’s new data points tell those with food allergies where to find Nima-tested dishes at chain restaurants throughout the world.
